Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
IRIX [NASD]
IRIDEX Corporation
Index- P/E40.47 EPS (ttm)0.17 Insider Own2.40% Shs Outstand9.88M Perf Week-4.71%
Market Cap67.97M Forward P/E24.57 EPS next Y0.28 Insider Trans36.18% Shs Float9.28M Perf Month-6.39%
Income1.70M PEG1.35 EPS next Q0.02 Inst Own52.40% Short Float0.07% Perf Quarter-10.30%
Sales41.00M P/S1.66 EPS this Y-27.30% Inst Trans-1.18% Short Ratio0.43 Perf Half Y-20.92%
Book/sh2.59 P/B2.66 EPS next Y75.00% ROA5.20% Target Price10.00 Perf Year14.67%
Cash/sh1.31 P/C5.27 EPS next 5Y30.00% ROE6.60% 52W Range5.87 - 11.00 Perf YTD-32.35%
Dividend- P/FCF75.53 EPS past 5Y17.70% ROI10.40% 52W High-35.91% Beta1.46
Dividend %- Quick Ratio3.30 Sales past 5Y-4.60% Gross Margin49.30% 52W Low20.10% ATR0.34
Employees101 Current Ratio4.90 Sales Q/Q15.20% Oper. Margin5.40% RSI (14)43.49 Volatility6.22% 4.08%
OptionableNo Debt/Eq0.00 EPS Q/Q-25.00% Profit Margin4.10% Rel Volume0.58 Prev Close6.88
ShortableYes LT Debt/Eq0.00 EarningsJul 31 AMC Payout0.00% Avg Volume14.97K Price7.05
Recom1.00 SMA20-2.41% SMA50-7.19% SMA200-15.86% Volume2,300 Change2.47%
03-Jan-07Initiated First Albany Buy $15.50
23-Oct-14 04:05PM  IRIDEX Announces Third Quarter 2014 Conference Call and Release Date PR Newswire
17-Oct-14 06:30AM  IRIDEX to Host MicroPulse┬« Worldwide 3-Day Forum at the American Academy of Ophthalmology PR Newswire
14-Oct-14 06:30AM  IRIDEX Expands Retinal Portfolio PR Newswire
07-Oct-14 06:30AM  IRIDEX Granted U.S. Patent for Disposable MicroPulse┬« Delivery Device for the Non-invasive Treatment of Glaucoma PR Newswire
01-Oct-14 04:05PM  IRIDEX Reports Strong Attendance at European Workshop for its Proprietary MicroPulse┬« Laser Therapy for Retina and Glaucoma Applications PR Newswire
26-Sep-14 06:02PM  Nasdaq stocks posting largest volume decreases AP
27-Aug-14 06:30AM  IRIDEX to Present at Robert W. Baird 2014 Health Care Conference PR Newswire
12-Aug-14 01:04PM  IRIDEX CORP Financials EDGAR Online Financials
07-Aug-14 01:00PM  Director Garrett A. Garrettson, Ph.D. to Step Down After Decade-Long Service PR Newswire
05-Aug-14 04:05PM  IRIDEX to Present at 2014 Wedbush Life Sciences Management Access Conference PR Newswire
04-Aug-14 04:06PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
31-Jul-14 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:31PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 Second Quarter, Six-Month Results PR Newswire
07:07AM  Q2 2014 IRIDEX Earnings Release - After Market Close CCBN
24-Jul-14 04:05PM  IRIDEX Announces Second Quarter 2014 Conference Call and Release Date PR Newswire
22-May-14 06:30AM  IRIDEX Announces New Multi-Center Study Data Demonstrates Safety, Durability of Proprietary MicroPulse Technology for Treatment of Glaucoma PR Newswire
05-May-14 04:36PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
04-May-14 02:43AM  IRIDEX's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
01-May-14 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:32PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2014 First Quarter Results PR Newswire
07:07AM  Q1 2014 IRIDEX Earnings Release - After Market Close CCBN
24-Apr-14 04:05PM  IRIDEX Announces First Quarter 2014 Conference Call and Release Date PR Newswire
22-Apr-14 06:30AM  IRIDEX Announces Proprietary MicroPulse Technology For Treatment Of Eye Diseases Caused By Diabetes And Age-Related Macular Degeneration Featured On 'American Health Front' Program PR Newswire
10-Apr-14 10:27AM  Low-Priced Stock Buys: New Treatments For Eye Disease, Respiratory Difficulties at Forbes
27-Mar-14 05:19PM  IRIDEX CORP Files SEC form 10-K, Annual Report EDGAR Online
27-Feb-14 09:00PM  IRIDEX Management Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2013 Fourth Quarter Results PR Newswire
07:07AM  Q4 2013 IRIDEX Earnings Release - After Market Close CCBN
20-Feb-14 04:05PM  IRIDEX Announces Fourth Quarter and Full Year 2013 Conference Call and Release Date PR Newswire
29-Jan-14 05:23PM  IRIDEX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
28-Jan-14 06:30AM  IRIDEX Announces Preliminary Unaudited Revenues For 2013 Fourth Quarter and Year End PR Newswire -5.35%
09-Jan-14 06:01AM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
10-Dec-13 04:57PM  IRIDEX CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
28-Nov-13 10:00AM  Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside at Seeking Alpha
13-Nov-13 02:14PM  IRIDEX To Introduce Four New Products At Annual AAO Meeting PR Newswire +8.66%
07-Nov-13 06:30AM  IRIDEX Promotes Timothy D. Buckley to Vice President of Marketing and North American Sales PR Newswire
06-Nov-13 11:28AM  Iridex - In The Early Innings Of Margin Expansion at Seeking Alpha
04-Nov-13 04:45PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online +9.95%
31-Oct-13 08:50PM  IRIDEX Management Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:30PM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:05PM  IRIDEX Reports 2013 Third Quarter Results PR Newswire
07:07AM  Q3 2013 IRIDEX Earnings Release - After Market Close CCBN
24-Oct-13 04:05PM  IRIDEX Announces Third Quarter 2013 Conference Call and Release Date PR Newswire
26-Sep-13 06:09PM  Nasdaq stocks posting largest volume decreases AP
06:30AM  Upcoming Global Medical Conferences to Feature IRIDEX Proprietary MicroPulse Laser Therapy PR Newswire
17-Sep-13 04:05PM  IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference PR Newswire
09-Sep-13 09:49AM  Air T Inc Director Buys 23K Shares and 5 Insider Sales to Note at Wall St. Cheat Sheet
14-Aug-13 01:00PM  [video] Iridex Eyes BRICs To Laser Ahead at TheStreet
13-Aug-13 09:46AM  KeyCorp CFO Buys 17K Shares and 4 Insider Buys to Note at Wall St. Cheat Sheet
06-Aug-13 04:05PM  IRIDEX to Present at 2013 Wedbush Securities Life Sciences Management Access Conference PR Newswire
05-Aug-13 04:37PM  IRIDEX CORP Files SEC form 10-Q, Quarterly Report EDGAR Online
01-Aug-13 05:00PM  IRIDEX Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  IRIDEX Reports 2013 Second Quarter Results; $9.2 Million Record Q2 Revenue PR Newswire
09:32AM  IRIDEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2013 IRIDEX Earnings Release - After Market Close CCBN
25-Jul-13 04:05PM  IRIDEX Announces Second Quarter 2013 Conference Call and Release Date PR Newswire
08-Jul-13 11:31PM  IRIDEX CORP Files SEC form 8-K, Other Events EDGAR Online
17-Jun-13 09:11AM  IRIDEX CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events EDGAR Online
11-Jun-13 04:06PM  InPlay: IRIDEX announces automatic conversion of series a preferred stock to common stock Briefing.com
04:05PM  IRIDEX Announces Automatic Conversion of Series A Preferred Stock to Common Stock PR Newswire
IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases worldwide. Its ophthalmology products consist of laser consoles, such as visible (yellow) photocoagulator console, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations. The company also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; and operating microscope adapters. In addition, it offers EndoProbe, a fiber optic delivery device used for endophotocoagulation, a retinal treatment procedure; G-Probe, a sterile consumable multi-use product used in procedures to treat medically and surgically uncontrolled glaucoma; and DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears. Further, the company provides GreenTip Soft Tip Cannula, a sterile disposable product, which allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAWKINS JAMES BDirectorAug 22Option Exercise4.866002,91631,894Aug 22 07:37 PM
HAWKINS JAMES BDirectorAug 22Sale8.036004,81831,294Aug 22 07:37 PM
MOORE WILLIAM MChairman and CEOAug 19Option Exercise4.3015,00064,50097,396Aug 27 05:13 PM
HAWKINS JAMES BDirectorAug 15Option Exercise4.861,9009,23433,194Aug 15 06:46 PM
HAWKINS JAMES BDirectorAug 15Sale8.071,90015,33431,294Aug 15 06:46 PM
HAWKINS JAMES BDirectorAug 14Option Exercise4.862,71413,19034,008Aug 15 06:46 PM
HAWKINS JAMES BDirectorAug 14Sale8.082,71421,93231,294Aug 15 06:46 PM
HAWKINS JAMES BDirectorAug 13Option Exercise4.869,78647,56041,080Aug 15 06:46 PM
HAWKINS JAMES BDirectorAug 13Sale8.119,78679,34631,294Aug 15 06:46 PM
GARRETTSON GARRETT ADirectorAug 11Option Exercise6.193,75023,21342,251Aug 12 07:12 PM
GARRETTSON GARRETT ADirectorAug 11Sale8.302,81023,32339,441Aug 12 07:12 PM
Steckel RonaldVP, OperationsJul 31Option Exercise3.997613,0362,725Aug 01 07:36 PM
Steckel RonaldVP, OperationsJul 31Sale8.007616,0881,964Aug 01 07:36 PM
Mackaness James HCFO and COOJul 21Option Exercise4.311,0004,3103,000Jul 23 06:42 PM
Mackaness James HCFO and COOJul 21Sale7.621,0007,6152,000Jul 23 06:42 PM
FITCH SANFORDDirectorJul 14Option Exercise2.465,00012,30035,344Jul 15 06:40 PM
Mackaness James HCFO and COOJun 23Option Exercise0.902,0001,8003,000Jun 24 07:08 PM
Mackaness James HCFO and COOJun 23Sale8.242,00016,4882,000Jun 24 07:08 PM
Steckel RonaldVP, OperationsJun 17Option Exercise3.941,6506,5002,989Jun 18 06:21 PM
Steckel RonaldVP, OperationsJun 17Sale8.201,65013,5351,964Jun 18 06:21 PM
FITCH SANFORDDirectorJun 06Option Exercise5.265,00026,3005,000Jun 09 06:51 PM
BlueLine Catalyst Fund IX, L.PDirectorJun 06Buy8.327,39061,4852,517,533Jun 09 04:44 PM
FITCH SANFORDDirectorJun 06Sale8.395,00041,9500Jun 09 06:51 PM
MOORE WILLIAM MChairman and CEOJun 03Buy8.485,00042,40082,396Jun 04 05:17 PM
Mackaness James HCFO and COOMay 21Option Exercise0.903,0002,7003,000May 22 06:52 PM
Mackaness James HCFO and COOMay 21Sale8.733,00026,1892,000May 22 06:52 PM
Steckel RonaldVP, OperationsMay 19Option Exercise3.941,6506,5002,989May 20 04:53 PM
Steckel RonaldVP, OperationsMay 19Sale8.821,65014,5451,964May 20 04:53 PM
MOORE WILLIAM MChairman and CEOMay 09Buy8.405,00042,00078,944May 13 04:58 PM
Mackaness James HCFO and COOApr 22Option Exercise0.901,0009003,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 22Sale9.001,0009,0002,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 21Option Exercise0.903,0002,7004,000Apr 23 06:28 PM
Mackaness James HCFO and COOApr 21Sale8.653,00025,9562,000Apr 23 06:28 PM
Steckel RonaldVP, OperationsApr 17Option Exercise3.941,6506,5002,989Apr 21 06:24 PM
Steckel RonaldVP, OperationsApr 17Sale8.881,65014,6521,964Apr 21 06:24 PM
Mackaness James HCFO and COOMar 21Option Exercise0.904,0003,6003,000Mar 24 08:20 PM
Mackaness James HCFO and COOMar 21Sale9.034,00036,1392,000Mar 24 08:20 PM
Steckel RonaldVP, OperationsMar 17Option Exercise3.941,6506,5002,275Mar 19 07:50 PM
Steckel RonaldVP, OperationsMar 17Sale9.071,65014,9661,250Mar 19 07:50 PM
GARRETTSON GARRETT ADirectorMar 04Option Exercise6.3911,25071,88841,049Mar 06 05:59 PM
GARRETTSON GARRETT ADirectorMar 04Sale9.224,99346,05436,056Mar 06 05:59 PM
GARRETTSON GARRETT ADirectorFeb 27Option Exercise5.265,00026,30030,899Feb 27 09:11 PM
Steckel RonaldVP, OperationsFeb 18Option Exercise3.941,6506,50036,850Feb 19 05:26 PM
Steckel RonaldVP, OperationsFeb 18Sale8.601,65014,19022,625Feb 19 05:26 PM
Steckel RonaldVP, OperationsJan 17Option Exercise3.941,6506,50037,875Jan 21 05:57 PM
Steckel RonaldVP, OperationsJan 17Sale10.421,65017,19323,250Jan 21 05:57 PM
Steckel RonaldVP, OperationsDec 17Option Exercise3.941,6506,50038,900Dec 18 04:44 PM
Steckel RonaldVP, OperationsDec 17Sale8.561,65014,12423,875Dec 18 04:44 PM
Mackaness James HCFO and COODec 02Option Exercise2.4910,00024,90010,000Dec 03 04:35 PM
Mackaness James HCFO and COODec 02Sale10.5210,000105,2180Dec 03 04:35 PM
Steckel RonaldVP, OperationsNov 18Option Exercise3.941,6506,50039,925Nov 20 04:18 PM
Steckel RonaldVP, OperationsNov 18Sale8.691,65014,33924,500Nov 20 04:18 PM
Mackaness James HCFO and COONov 06Option Exercise2.4910,00024,90025,000Nov 08 04:25 PM
Mackaness James HCFO and COONov 06Sale8.3510,00083,49615,000Nov 08 04:25 PM